TABLE OF CONTENTS | |||||||||||||||||||||||||||||||||||||
April 2016 Volume 12 Number 4 | |||||||||||||||||||||||||||||||||||||
In this issue Research Highlights News and Views Reviews
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
NEWS AND VIEWS | Top | ||||||||||||||||||||||||||||||||||||
Diabetes: Stress resilience and risk of type 2 diabetes mellitus Andrew Steptoe Published online: 05 February 2016 p189 | doi:10.1038/nrendo.2016.17 The ability of people to resist the consequences of psychological stress and cope effectively with the challenges of life might be associated with reduced risk of future type 2 diabetes mellitus, according to a very large study of young men followed-up into middle age. Full Text | PDF | |||||||||||||||||||||||||||||||||||||
Therapy: New findings on vitamin D3 supplementation and falls — when more is perhaps not better Kerrie M. Sanders & Markus J. Seibel Published online: 26 February 2016 p190 | doi:10.1038/nrendo.2016.29 Results from a recent randomized controlled trial on vitamin D3 supplementation suggest that even modestly high doses of vitamin D3, when given once monthly, might be associated with an increased rate of falls in older people. These findings support the conservative approach of the Institute of Medicine's recommendations of 800 IU of vitamin D3 per day for older adults. Full Text | PDF | |||||||||||||||||||||||||||||||||||||
Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
REVIEWS | Top | ||||||||||||||||||||||||||||||||||||
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma Cristina Romei, Raffaele Ciampi & Rossella Elisei Published online: 12 February 2016 p192 | doi:10.1038/nrendo.2016.11 Since mutations in the RET proto-oncogene were discovered in thyroid carcinoma 20 years ago, research has focused on determining the prevalence of these alterations, their role in disease development and potential clinical applications. In this Review, the authors discuss these findings with respect to the pathogenic, diagnostic and prognostic roles of RET in patients with papillary thyroid carcinoma and medullary thyroid carcinoma. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
BMP signalling in skeletal development, disease and repair Valerie S. Salazar, Laura W. Gamer & Vicki Rosen Published online: 19 February 2016 p203 | doi:10.1038/nrendo.2016.12 Bone morphogenetic proteins (BMPs) have been implicated in almost all aspects of bone, cartilage and joint biology. Here, Valerie Salazar and colleagues discuss BMP superfamily signalling in the context of skeletal development and joint morphogenesis, and summarize the status of the BMP pathway as a therapeutic target for treating skeletal trauma and disease. Abstract | Full Text | PDF | Supplementary information | |||||||||||||||||||||||||||||||||||||
Diabetic emergencies — ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia Guillermo Umpierrez & Mary Korytkowski Published online: 19 February 2016 p222 | doi:10.1038/nrendo.2016.15 Diabetic ketoacidosis, hyperglycaemic osmolar state and hypoglycaemia are serious complications of diabetes mellitus. Here, Guillermo Umpierrez and Mary Korytkowski discuss the clinical presentation, precipitating causes, diagnosis and acute management of these diabetic emergencies and suggest practical strategies for their prevention. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
Hypophosphatasia — aetiology, nosology, pathogenesis, diagnosis and treatment Michael P. Whyte Published online: 19 February 2016 p233 | doi:10.1038/nrendo.2016.14 Hypophosphatasia — a form of metabolic bone disease characterized by low serum alkaline phosphatase activity — results from loss-of-function mutations in the gene encoding the tissue-nonspecific isoenzyme of alkaline phosphatase (TNSALP). Here, Michael Whyte discusses the aetiology, nosology, pathogenesis, diagnosis and treatment of hypophosphatasia, which is particularly timely given the recently reported successes and approvals of treating the disease using asfotase alfa, a bone-targeted, recombinant TNSALP. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
|
*Journal Citation Reports, Thomson, 2014. Nature Reviews Endocrinology was previously published as Nature Clinical Practice Endocrinology & Metabolism. |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
No comments:
Post a Comment
Keep a civil tongue.